Analytical development

Product Description
Ingenza ltd

-
GB
-
2025On CPHI since
-
50 - 99Employees
Company types
Primary activities
Categories
Ingenza ltd

-
GB
-
2025On CPHI since
-
50 - 99Employees
Company types
Primary activities
More Products from Ingenza ltd (2)
-
Product Material Manufacture
Material for pre-clinical, pre-formulation and stability testing using optimised hosts and individually tailored manufacturing process. -
Product Process demonstration
(Chemo)-enzymatic synthesis of chemical entities or natural products exemplified in shake flask and scalable fermentations. Bioprocesses engineered with over 70 parameters monitored and optimised (upstream & downstream). Process design for target prepar...
Ingenza ltd resources (1)
-
Industry Webinar Enzymatic Precision: Advancing Complex Small Molecule Synthesis using Biocatalysis
Synthetic chemistry is the default approach for pharmaceutical small molecule manufacturing, able to prepare diverse molecular entities, not found in nature, using well proven methodologies. However, in recent years, small molecule therapeutics have become increasingly complex in design to provide greater potency, efficacy and specificity. This industry trend poses additional challenges for synthetic chemistry to deliver effective manufacturing routes that are atom-efficient, scalable, low-cost and sustainable, particularly where stereo- and/or regio-selective syntheses are necessary. This webinar highlights the opportunity for the exquisite selectivity of enzymatic biotransformations, conducted in vitro or in vivo, to overcome these challenges of tomorrow’s small molecule pharmaceutical manufacturing.